136 related articles for article (PubMed ID: 24108104)
21. Delivery of recombinant adeno-associated virus vectors to rat diaphragm muscle via direct intramuscular injection.
Smuder AJ; Falk DJ; Sollanek KJ; Nelson WB; Powers SK
Hum Gene Ther Methods; 2013 Dec; 24(6):364-71. PubMed ID: 24006956
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of a SOD1-targeting artificial miRNA delivered by AAV9 in mice are impacted by miRNA scaffold selection.
Chen SK; Hawley ZCE; Zavodszky MI; Hana S; Ferretti D; Grubor B; Hawes M; Xu S; Hamann S; Marsh G; Cullen P; Challa R; Carlile TM; Zhang H; Lee WH; Peralta A; Clarner P; Wei C; Koszka K; Gao F; Lo SC
Mol Ther Nucleic Acids; 2023 Dec; 34():102057. PubMed ID: 37928442
[TBL] [Abstract][Full Text] [Related]
23. SpinoBot: An MRI-Guided Needle Positioning System for Spinal Cellular Therapeutics.
Squires A; Oshinski JN; Boulis NM; Tse ZTH
Ann Biomed Eng; 2018 Mar; 46(3):475-487. PubMed ID: 29150766
[TBL] [Abstract][Full Text] [Related]
24. Intraspinal injection of adeno-associated viruses into the adult mouse spinal cord.
Chaterji S; Barik A; Sathyamurthy A
STAR Protoc; 2021 Sep; 2(3):100786. PubMed ID: 34505088
[TBL] [Abstract][Full Text] [Related]
25. Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis.
Wang GY; Rayner SL; Chung R; Shi BY; Liang XJ
Mater Today Bio; 2020 Mar; 6():100055. PubMed ID: 32529183
[TBL] [Abstract][Full Text] [Related]
26. Intrathecal Vector Delivery in Juvenile Rats via Lumbar Cistern Injection.
Donsante A; Rasmussen SA; Fridovich-Keil JL
J Vis Exp; 2024 Mar; (205):. PubMed ID: 38619261
[TBL] [Abstract][Full Text] [Related]
27. Intrathecal gene therapy for neurologic disease in humans.
Flotte TR
Mol Ther; 2024 May; 32(5):1185-1186. PubMed ID: 38663405
[No Abstract] [Full Text] [Related]
28. Intrathecal Injection of Newborn Mouse for Genome Editing and Drug Delivery.
Lu X; Jiang YH
J Vis Exp; 2024 Mar; (205):. PubMed ID: 38526075
[TBL] [Abstract][Full Text] [Related]
29. A Single Transcript Knockdown-Replacement Strategy Employing 5' UTR Secondary Structures to Precisely Titrate Rescue Protein Translation.
Millette MM; Holland ED; Tenpas TJ; Dent EW
Front Genome Ed; 2022; 4():803375. PubMed ID: 35419562
[TBL] [Abstract][Full Text] [Related]
30. Safe and Effective Cynomolgus Monkey GLP-Tox Study with Repetitive Intrathecal Application of a TGFBR2 Targeting LNA-Gapmer Antisense Oligonucleotide as Treatment Candidate for Neurodegenerative Disorders.
Peters S; Wirkert E; Kuespert S; Heydn R; Johannesen S; Friedrich A; Mailänder S; Korte S; Mecklenburg L; Aigner L; Bruun TH; Bogdahn U
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057094
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic rAAVrh10 Mediated SOD1 Silencing in Adult SOD1(G93A) Mice and Nonhuman Primates.
Borel F; Gernoux G; Cardozo B; Metterville JP; Toro Cabrera GC; Song L; Su Q; Gao GP; Elmallah MK; Brown RH; Mueller C
Hum Gene Ther; 2016 Jan; 27(1):19-31. PubMed ID: 26710998
[TBL] [Abstract][Full Text] [Related]
32. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
33. Slow Intrathecal Injection of rAAVrh10 Enhances its Transduction of Spinal Cord and Therapeutic Efficacy in a Mutant SOD1 Model of ALS.
Li D; Liu C; Yang C; Wang D; Wu D; Qi Y; Su Q; Gao G; Xu Z; Guo Y
Neuroscience; 2017 Dec; 365():192-205. PubMed ID: 29024785
[TBL] [Abstract][Full Text] [Related]
34. Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection.
McLean JR; Smith GA; Rocha EM; Hayes MA; Beagan JA; Hallett PJ; Isacson O
Neurosci Lett; 2014 Jul; 576():73-8. PubMed ID: 24882721
[TBL] [Abstract][Full Text] [Related]
35. Silencing strategies for therapy of SOD1-mediated ALS.
van Zundert B; Brown RH
Neurosci Lett; 2017 Jan; 636():32-39. PubMed ID: 27507699
[TBL] [Abstract][Full Text] [Related]
36. SOD1 silencing in motoneurons or glia rescues neuromuscular function in ALS mice.
Dirren E; Aebischer J; Rochat C; Towne C; Schneider BL; Aebischer P
Ann Clin Transl Neurol; 2015 Feb; 2(2):167-84. PubMed ID: 25750921
[TBL] [Abstract][Full Text] [Related]
37. Selection of Potential Pharmacological Targets in ALS Based on Whole- Genome Expression Profiling.
Morello G; Conforti FL; Parenti R; D'Agata V; Cavallaro S
Curr Med Chem; 2015; 22(17):2004-21. PubMed ID: 25850769
[TBL] [Abstract][Full Text] [Related]
38. Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates.
Meyer K; Ferraiuolo L; Schmelzer L; Braun L; McGovern V; Likhite S; Michels O; Govoni A; Fitzgerald J; Morales P; Foust KD; Mendell JR; Burghes AH; Kaspar BK
Mol Ther; 2015 Mar; 23(3):477-87. PubMed ID: 25358252
[TBL] [Abstract][Full Text] [Related]
39. Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice.
Ayers JI; Fromholt S; Sinyavskaya O; Siemienski Z; Rosario AM; Li A; Crosby KW; Cruz PE; DiNunno NM; Janus C; Ceballos-Diaz C; Borchelt DR; Golde TE; Chakrabarty P; Levites Y
Mol Ther; 2015 Jan; 23(1):53-62. PubMed ID: 25228069
[TBL] [Abstract][Full Text] [Related]
40. Global CNS transduction of adult mice by intravenously delivered rAAVrh.8 and rAAVrh.10 and nonhuman primates by rAAVrh.10.
Yang B; Li S; Wang H; Guo Y; Gessler DJ; Cao C; Su Q; Kramer J; Zhong L; Ahmed SS; Zhang H; He R; Desrosiers RC; Brown R; Xu Z; Gao G
Mol Ther; 2014 Jul; 22(7):1299-1309. PubMed ID: 24781136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
